1548 results for Leukemia
Refine Your Search
Cellular Crosstalk In The Normal And Malignant Bone Marrow
We want to understand how leukemia inhibits blood production as this is one of the main causes of death in leukemia patients. We use new microscopy te…
Feeling uncertain? Start here.
If you need information or support: There’s a lot to take in with a blood cancer diagnosis: medical realities, treatment options, and the sheer emotio…
Aberrant LZTR1 and RIT1 signaling as a driver of clonal hematopoietic disorders
Our research focuses on a novel mechanism of RAS protein regulation via the protein LZTR1, which is altered in leukemia and hinders the effectiveness …
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
SAN DIEGO, May , - BioTheryX, Inc., a company focused on degrading proteins to create cancer medicines, today announced a $ million Series E financ…
Creating Great Investigators: LLS’s New Pathway To Medical Science For Underrepresented Minorities
Black, Indigenous, and People of Color (BIPOC), Latinos, Native Hawaiians, Pacific Islanders, and other minority groups are underrepresented in the me…
John Crispino
Dr. John Crispino is Chief of the Division of Experimental Hematology at St. Jude Children’s Research Hospital. He received his PhD from MIT for resea…
Daniel Lucas
Daniel Lucas uses microscopy to understand how blood cells are produced in the marrow of the bone and how leukemia inhibits this process. A native Spa…
Aileen Rowan
After completing a PhD in Immunology at Trinity College Dublin, I moved to Imperial College London to study how persistent infection with a virus caus…
Zuzana Tothova
Dr. Zuzana Tothova is an Assistant Professor of Medicine at Harvard Medical School and the Cancer Institute, and an Associate Member of the Broad Ins…
Continued Collaboration Fuels Hope for Rare Blood Cancer Treatments
The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society, now Blood Cancer United, have renewed their partnership to support the …
News Release
Follow-Up Care
Click here for information about care, including what to expect, and late effects of treatment, survivorship clinics, and other resources such as Th…
Judy
Meet Judy, a leukemia survivor, and teacher. Given a death sentence of chronic myeloid leukemia (CML), Oregon native Judy prepared to have her ashes s…
Champions in myeloma research, Part 2: A conversation with Suzanne Lentzsch, M.D., Ph.D.
To commemorate both Myeloma Awareness Month and Women’s History Month during March, I’ve been talking with women scientists who are driving discovery…
T-cell lymphomas (TCL)
lymphomas comprise approximately -% of all ’s Lymphomas (NHLs). The main subsets are peripheral lymphoma (PTCL) and cutaneous lymphoma (CTCL). PTCLs…
Research: Grants
Research: TAP
Stars Will Twinkle, The Sun Will Shine
Stars Will Twinkle, The Sun Will Shine: The Story of Olivia’s Leukemia By Teresita Blake Kellenyi, Illustrated by Angie Jones The Leukemia & Lymphom…
Functional and mechanistic roles of BCAA metabolism in the progression of myeloproliferative neoplasms
The processes that control the progression of myeloproliferative neoplasms to leukemic transformation remain largely unknown. We have developed geneti…
Understanding and Overcoming Mechanisms of Immune Evasion after Allogeneic Transplant
Outcomes for patients with acute myelogenous leukemia who relapse after transplantation are dismal. This SCOR brings together an international group o…
Booklet Updates
Blood Cancer United wants you to have the most information about blood cancer treatment. See below for new treatments that have been FDA approved sin…
Enhancing the cytotoxicity of T cells in NRAS; ASXL1-AML through combined inhibition of MEK and HDACs
Acute myeloid leukemia (AML) is a heterogeneous malignant blood cancer. Its treatment outcome is influenced by the mutations. Oncogenic NRAS mutation…
Practicing Self-Advocacy During My PTCL Journey
The LLS Blog invites Aaron, who was diagnosed with peripheral lymphoma (PTCL), to share his reflections on becoming a throughout his cancer experien…
FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma
Chimeric Antigen Receptor (CAR) T is on a roll. Today marks the seventh approval of CAR T therapy since the first approval in .
Mechanisms of Pathogenesis by MYB Fusions in Blastic Plasmacytoid Dendritic Cell Neoplasm
The transcription factor MYB has long been associated with leukemia, but how it contributes to disease is poorly understood. Fusions of MYB to other p…
Lymphoma diagnosis, survival rate by age, prognosis, and treatment
Table of contents:What is Hodgkin lymphoma? Organs affected by Hodgkin lymphomaHodgkin lymphoma symptoms and early signsWhat is lymphoma?Organs affec…
Pam
Pam Katten died on September , after a battle with acute myeloid leukemia (AML). Pam was an extraordinary woman, beloved as a mother, daughter, sis…
ImCheck Therapeutics
Marseille, France - ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel…
Research: TAP